Research Focus: 

Personality aspects in psychosomatic disorders and chronic neurogenic diseases

Publications

• 1. A. Edelmann, L. Nocke-Finck, F. Gullotta: Endocrine effects exerted by tumors of the
  pineal region. (1984) 2 nd European Conference for Neuropathology, Sep 20-22, Warshaw,
  Poland, p. 15
• 2. A. Edelmann, L. Nocke-Finck, W. Entzian, F. Gullotta: Non-specific lymphocytic
  hypophysitis causing panhypopituitarism in a male patient (1984). 2 nd European
  Conference for Neuropathology, Sep 20-22, Warshaw, Poland, p. 16
• 3. K. Kraft, A. Edelmann, W. Entzian, L. Nocke-Finck: Suppression of plasma prolactin in a
  patient with a pinealocytoma (1984). Horm. Metabol. Res. 16, 324-325
• 4. A. Edelmann, A. Allera, GS Rao: Dopaminergic receptors on cultivated rat pituitary cells
  characterized by spiroperidol binding (1985). J. Endocrinol. Invest. 8, Suppl. 3, 140
• 5. A. Edelmann, L. Radbruch, L. Nocke-Finck: Endocrinological long term follow-up study of
  patients bilaterally adrenalectomized for Cushings’s disease (1987). Acta Endocrinol. 114,
  Suppl. 283, 107
• 6. M. Edelmann, W. Kozuschek, A. Edelmann, D. Sonntag: Die endokrine Pankreasfunktion
  nach unterschiedlicher Pankreasresektion von Patienten mit chronischer Pankreatitis
  (1987). Langenbeck’s Archiv für Chirurgie 372, 877
• 7. U. Hennes, A. Edelmann: Endocrine effects of the new antimycotic drug amorolfine
  Ro-14-4767/002 after oral application (1987). Acta Endocrinol. 114, Suppl. 283, 105-106
• 8. A. Edelmann, M. Zulauf: Influence of micellar lipid composition on cholesterol uptake in
  the human enterocytic cell line Caco-2 (1989). X. International Symposium on Drugs
  Affecting Lipid Metabolism, Houston, Nov 8-11, 1989; Abstract 721
• 9. A. Edelmann: Uptake of micellar cholesterol and transcellular transport in the human
  enterocytic cell line Caco-2 (1990). J. Endocrinol. Invest. 13, Suppl. 2, 311
• 10. U. Hennes, A. Edelmann, R. Imhof: Influence of specific domine autoreceptor agonists on
  anterior pituitary hormone secretion (1990). J. Endocrinol. Invest. 13, Suppl. 2, 291
• 11. J. Himber, U. Hennes, A. Edelmann: Influence of cholestyramine, mevinolin and the intestinal cholesterol absorption inhibitor Ro 16-6532 on lipoprotein metabolism in the hypercholesterolemic male hamster (1991). 9 th International Symposium on Atherosclerosis, Oct. 6-11, Rosemont, Ill., USA, Abstract 87, p. 182
• 12. JP Keogh, A. Edelmann, A. Fischli: Chromatographic measurement of mucin productionin cultures of gastric mucous cells (1991). Biochem. Int. 25, 621-630
• 13. U. Hennes, W. Gross, A. Edelmann: Changes of lipoprotein patterns in hamsters under different metabolic states analyzed following separation by micro-preparative chromatography on SMART TM system from multiple micro plasma samplings (1992). Science Tools 36, 10-12
• 14. M. Hogardt, A. Edelmann: Possible role of carboxylester lipase (CEL) and pancreatic phospholipase A 2 for intestinal cholesterol absorption (1992). XI. International Symposium on Drugs Affecting Lipid Metabolism, Florence, Italy, May 13-16, p. 151
• 15. A. Edelmann, P. Verry, W. Bannwarth, J. Müller: Selective imaging of atherosclerotic plaques in aging WHHL rabbits with an apo B 1000-1016 fragment (1993). 62 nd European Atherosclerosis Society Congress, Sept. 5-9, Jerusalem, Israel, p.87
• 16. A. Edelmann, B. Galli, U. Hennes, A. Kistler, H. Kuhn, F. Mettler: Prolactin lowering activity of the retinoid Ro 14-9706 affecting lactation and pup survival (1994). Archives of Toxicology 68, 385-394
• 17. A. Edelmann, K. Edelmann-Stergiou, R. Scharpf: Audits of specialized laboratories and centralized reader institutions. Approaches, problems, and solutions (2015), p. 130-155. In : Audits in GCP and Beyond, Methods and Experiences, 3 rd revised and enlarged edition, by the German Society for Good Research Practice (DGGF) (2015); Editio Cantor Verlag ISBN 978-3-87193-410-0
• 18. A. Edelmann: Die Bedeutung der Psyche bei chronischen Atemwegserkrankungen (2018). Erfahrungsheilkunde 67(05): 301-306; doi: 10.1055/a-0740-0188